相关实验视频

Updated: Jun 8, 2025

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

纳米粒子载体:精确CRISPR/Cas9基因编辑的新时代

Bhawna Sharma¹, Iti Chauhan², Gaurav Kumar³

¹Department of Pharmaceutics, Dr. K. N. MODI Institute of Pharmaceutical Education and Research, Modinagar, Ghaziabad, UP, India.

MicroRNA (Shariqah, United Arab Emirates)

|November 1, 2024

概括

纳米粒子为提供CRISPR/Cas9基因编辑技术提供了一个有希望的解决方案,克服了遗传疾病和癌症的传递挑战. 这些多功能载体提高了效率,并使向治疗成为可能.

科学领域:

生物技术是生物技术.
纳米医学是一种纳米医学.
基因治疗基因治疗

背景情况:

在基因疾病和癌症方面,CRISPR/Cas9基因编辑显示出有前途.
有效提供CRISPR/Cas9组件是一个主要障碍.
纳米粒子正在成为先进的药物输送系统.

研究的目的:

探索基于纳米粒子的传递系统在CRISPR/Cas9基因编辑中的潜力.
突出使用纳米颗粒用于CRISPR/Cas9传递的优势和挑战.
审查各种纳米粒子类型及其在基因编辑中的应用.

主要方法:

对基于纳米粒子的CRISPR/Cas9传递系统的当前文献的综述.
纳米粒子特性分析,包括尺寸适应,生产可扩展性和体内性能.
检查不同类型的纳米粒子 (聚合物,基于脂质的,黄金) 和它们的具体机制.

主要成果:

纳米粒子可以容纳更大的CRISPR/Cas9组件,使以前无法访问的遗传区域能够被编辑.
纳米粒子在体内表现出高效的组织透和有针对性的输送,最大限度地减少副作用.
各种纳米粒子 (聚合物,脂质基,黄金) 提供不同的优势,如可控释放,细胞吸收和向激活.

结论:

纳米粒子是用于CRISPR/Cas9基因编辑的有效和多功能非病毒传递系统.
它们的效率,安全性和可扩展性使它们成为未来基因编辑疗法的关键推动者.
纳米粒子介导的CRISPR/Cas9传递有可能彻底改变药物开发和个性化医学.

关键词:

在CRISPR的交付过程中.克里斯普尔/Cas9是什么意思未来的方面. 未来的方面.纳米颗粒是一种纳米粒子.

更多相关视频

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

Published on: June 20, 2019

Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9

Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9

Published on: August 25, 2018

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...